|
|
Volumn 375, Issue 21, 2016, Pages 2106-2108
|
|
Perioperative ledipasvir-sofosbuvir for HCV in liver-transplant recipients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
CREATININE;
LEDIPASVIR;
NONSTRUCTURAL PROTEIN 5A;
NONSTRUCTURAL PROTEIN 5B;
SOFOSBUVIR;
VIRUS RNA;
BENZIMIDAZOLE DERIVATIVE;
FLUORENE DERIVATIVE;
CREATININE CLEARANCE;
GENOTYPE;
GRAFT RECIPIENT;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
LETTER;
LIVER GRAFT;
LIVER TRANSPLANTATION;
MULTICENTER STUDY;
PERIOPERATIVE PERIOD;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
REINFECTION;
SINGLE DRUG DOSE;
VIREMIA;
BLOOD;
CLINICAL TRIAL;
GENETICS;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
ISOLATION AND PURIFICATION;
ANTIVIRAL AGENTS;
BENZIMIDAZOLES;
FLUORENES;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
HUMANS;
LIVER TRANSPLANTATION;
PERIOPERATIVE CARE;
RNA, VIRAL;
SOFOSBUVIR;
|
|
EID: 84996636488
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1611829 Document Type: Letter |
|
Times cited : (73)
|
|
References (4)
|
